Platelet Rich Plasma vs Corticosteroids for Hip Osteoarthritis
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are taking opioids or have had recent injections in the hip, you may not be eligible to participate.
What data supports the effectiveness of the treatment for hip osteoarthritis?
Research shows that platelet-rich plasma (PRP) injections can lead to long-term pain reduction and improved function in patients with hip osteoarthritis, with benefits lasting up to 12 months. Corticosteroids are known to provide immediate pain relief and improve mobility, although their long-term effectiveness is limited.12345
Is platelet-rich plasma (PRP) safe for treating osteoarthritis?
How does the treatment of platelet-rich plasma and corticosteroids differ from other treatments for hip osteoarthritis?
Platelet-rich plasma (PRP) and corticosteroids are used as intra-articular injections (injections into the joint) for hip osteoarthritis, with corticosteroids providing short-term pain relief and PRP potentially offering more mid-term benefits. This treatment is unique because it combines the immediate effects of corticosteroids with the regenerative potential of PRP, unlike other treatments like hyaluronic acid, which primarily focuses on lubrication.110111213
What is the purpose of this trial?
Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.
Eligibility Criteria
This trial is for individuals with hip osteoarthritis who are experiencing pain and functional issues. Specific eligibility criteria details were not provided, so it's important to contact the study organizers for more information on who can participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 5 mL injection of corticosteroid or approximately 10 mL of autologous PRP for the treatment of hip osteoarthritis
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, six weeks, and three months
Treatment Details
Interventions
- Corticosteroid
- Platelet Rich Plasma
Find a Clinic Near You
Who Is Running the Clinical Trial?
LifeBridge Health
Lead Sponsor
Hip Society
Collaborator